291 related articles for article (PubMed ID: 19026028)
1. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
[TBL] [Abstract][Full Text] [Related]
2. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
[TBL] [Abstract][Full Text] [Related]
3. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
Do C; Huyghe E; Lapeyre-Mestre M; Montastruc JL; Bagheri H
Drug Saf; 2009; 32(7):591-7. PubMed ID: 19530745
[TBL] [Abstract][Full Text] [Related]
4. Hepatic adverse drug reactions: a case/non-case study in Italy.
Motola D; Vargiu A; Leone R; Cocci A; Salvo F; Ros B; Meneghelli I; Venegoni M; Cutroneo PM; Vaccheri A; Velo G; Montanaro N
Eur J Clin Pharmacol; 2007 Jan; 63(1):73-9. PubMed ID: 17119945
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.
Leone R; Conforti A; Venegoni M; Motola D; Moretti U; Meneghelli I; Cocci A; Sangiorgi Cellini G; Scotto S; Montanaro N; Velo G
Drug Saf; 2005; 28(6):547-56. PubMed ID: 15924506
[TBL] [Abstract][Full Text] [Related]
6. Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins.
van Hunsel F; van Puijenbroek E; de Jong-van den Berg L; van Grootheest K
Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):26-32. PubMed ID: 19953500
[TBL] [Abstract][Full Text] [Related]
7. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.
Pariente A; Gregoire F; Fourrier-Reglat A; Haramburu F; Moore N
Drug Saf; 2007; 30(10):891-8. PubMed ID: 17867726
[TBL] [Abstract][Full Text] [Related]
8. Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy.
Motola D; Vargiu A; Leone R; Conforti A; Moretti U; Vaccheri A; Velo G; Montanaro N
Drug Saf; 2008; 31(7):609-16. PubMed ID: 18558794
[TBL] [Abstract][Full Text] [Related]
9. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
[TBL] [Abstract][Full Text] [Related]
10. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.
Aagaard L; Nielsen LH; Hansen EH
Drug Saf; 2009; 32(11):1067-74. PubMed ID: 19810778
[TBL] [Abstract][Full Text] [Related]
11. Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature.
Roberto G; Biagi C; Montanaro N; Koci A; Moretti U; Motola D
Eur J Clin Pharmacol; 2012 Jun; 68(6):1007-11. PubMed ID: 22286160
[TBL] [Abstract][Full Text] [Related]
12. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.
Edwards IR; Star K; Kiuru A
Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877
[TBL] [Abstract][Full Text] [Related]
13. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy.
Lapi F; Tuccori M; Motola D; Pugi A; Vietri M; Montanaro N; Vaccheri A; Leoni O; Cocci A; Leone R; Conforti A; Moretti U; Sessa E; Mazzaglia G; Mugelli A; Mazzei T; Vannacci A
Drug Saf; 2010 Sep; 33(9):789-99. PubMed ID: 20701411
[TBL] [Abstract][Full Text] [Related]
14. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
Fraunfelder FW; Richards AB
Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
[TBL] [Abstract][Full Text] [Related]
15. Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database.
Moulis G; Béné J; Sommet A; Sailler L; Lapeyre-Mestre M; Montastruc JL;
Lupus; 2012 Jul; 21(8):885-9. PubMed ID: 22333565
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy-related adverse events associated with statins: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS).
Wu T; Shi Y; Zhu B; Li D; Li Z; Zhao Z; Zhang Y
Expert Opin Drug Saf; 2024 Mar; 23(3):313-321. PubMed ID: 37612600
[TBL] [Abstract][Full Text] [Related]
17. Allergic reactions to oral drugs: A case/non-case study from an Italian spontaneous reporting database (GIF).
Salvo F; Polimeni G; Cutroneo PM; Leone R; Confortic A; Moretti U; Motola D; Tuccori M; Caputi AP
Pharmacol Res; 2008; 58(3-4):202-7. PubMed ID: 18692136
[TBL] [Abstract][Full Text] [Related]
18. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.
Golomb BA; McGraw JJ; Evans MA; Dimsdale JE
Drug Saf; 2007; 30(8):669-75. PubMed ID: 17696579
[TBL] [Abstract][Full Text] [Related]
19. Drug-related nephrotoxic and ototoxic reactions : a link through a predictive mechanistic commonality.
Verdel BM; van Puijenbroek EP; Souverein PC; Leufkens HG; Egberts AC
Drug Saf; 2008; 31(10):877-84. PubMed ID: 18759511
[TBL] [Abstract][Full Text] [Related]
20. Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system.
Xiao M; Li L; Zhu W; Wu F; Wu B
Expert Rev Clin Pharmacol; 2024 Mar; 17(3):255-261. PubMed ID: 38275183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
